2303只私募产品在11月创历史新高!16只“双十基金”在列!
Sou Hu Cai Jing·2025-12-16 11:20

Market Overview - In November, the A-share market continued the high-level fluctuations from October, with the three major indices all closing down: the Shanghai Composite Index fell by 1.67%, the Shenzhen Component Index decreased by 2.95%, and the ChiNext Index dropped by 4.23% [1] - Despite the overall market decline, 2,303 private equity products reached historical highs in net value in November, representing approximately 44.59% of private equity products established for over a year [1] Private Equity Product Types - Among the private equity products, 1,199 were non-quantitative, while 1,104 were quantitative. The majority were stock strategy products, with 1,362 products accounting for about 59.14% [1] - Other strategies included multi-asset strategy products (321), futures and derivatives strategy products (302), bond strategy products (233), and combination fund products (85) [1] Company Size and Performance - The largest number of products came from private equity firms with assets under 500 million, totaling 778 products (approximately 34%); firms with over 10 billion had 389 products [2] - A detailed analysis of the top 20 performing private equity products by strategy was provided, focusing on those with over 5 billion in assets [2] Long-Standing Products - Among the private equity products that reached historical highs, 20 were established for over 10 years, with 16 classified as "Double Ten Funds," achieving annualized returns exceeding 10% [3] - The majority of these long-standing products were subjective long-only products (12), with macro strategy and CTA products each having 3, and quantitative long-only and FOF funds each having 1 [3] Notable Products and Managers - The largest product by size was the macro strategy product "Kai Feng Macro Strategy No. 9" managed by Shenzhen Kai Feng Investment, established on July 29, 2015, with a scale of approximately *** billion and an annualized return close to ***% [4][6] - The quantitative CTA product "Shuanglong-Longyuan No. 1," managed by Shuanglong Investment, also showed significant performance with a scale of approximately *** billion and an annualized return close to ***% [6] Quantitative Long-Only Products - There were 515 products classified under the "stock-quantitative long-only" strategy among private equity products with over 5 billion in assets [7] - The top 5 performing products in this category were from Jin Tong Investment, Jiu Ming Investment, Han Rong Investment, and others, with the performance threshold for the top 20 being close to ***% [7] Subjective Long-Only Products - A total of 331 products were categorized as "stock-subjective long-only," with only one product from a firm with over 10 billion assets making it to the top 20 [11] - The top 5 products in this category were from Neng Jing Investment Holdings, Shanghai Ge Ru Private Equity, and others [11] Futures and Derivatives Strategy - There were 169 products under the "futures and derivatives strategy," with the top 5 performers coming from Yi Zu Investment, Hai Sheng Fund, and others [15] - The leading product was "Yi Zu Qing Gui Li Dong," managed by Lin Jianwei, with significant returns [18] Multi-Asset Strategy - A total of 207 products were classified under the "multi-asset strategy," with the top 5 performers from Juqi Investment, Hai Sheng Fund, and others [19] - The product "Xi Shi Run Huang Jin Zeng Qiang No. 1 A Class Share," managed by Guan Xin, was noted for its performance [23]